XML 30 R14.htm IDEA: XBRL DOCUMENT
v3.19.1

8. PRO FORMA FINANCIAL INFORMATION (UNAUDITED) | 3 Months Ended
--- | ---
Dec. 31, 2018
Pro Forma Financial Information |
PRO FORMA FINANCIAL INFORMATION (UNAUDITED) | The following unaudited pro-forma data summarizes the results of operations for the three months ended December 31, 2018 and 2017, as if the Mergers with Cure Based Development had been completed on October 1, 2017. The pro-forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the Mergers had taken place on October 1, 2017.
|  | Three Months Ended December 31, 2018 |  |  | Three Months Ended December 31, 2017 |
Net revenues |  | $ | 4,408,505 |  |  | $ | 688,110 |
Operating income (loss) |  | $ | (1,988,146 | ) |  | $ | (1,496,943 | )
Net income (loss) |  | $ | (3,368,270 | ) |  | $ | (1,401,860 | )
Net loss per share – basic and fully diluted |  | $ | (0.13 | ) |  | $ | (0.06 | )
For the per share calculation, it is being assumed that the shares to be issued contractually under the Merger Agreement, upon shareholder approval, have been issued. This would account for an additional 6,500,000 shares issued directly to the members of Cure Based Development and another 8,750,000 shares issued which would have a voting proxy and leak out on voting rights over a 5 year period.

X
- References No definition available. + Details
Name: | LEVB_ProFormaFinancialInformationDisclosureTextBlock
Namespace Prefix: | LEVB_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | LEVB_ProFormaFinancialInformationUnauditedAbstract
Namespace Prefix: | LEVB_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration